Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease

被引:42
作者
Miklossy, J
Taddei, K
Suva, D
Verdile, G
Fonte, J
Fisher, C
Gnjec, A
Ghika, J
Suard, F
Mehta, PD
McLean, CA
Masters, CL
Brooks, WS
Martins, RN
机构
[1] Temple Univ, Ctr Neurovirol & Canc Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA
[2] Univ Western Australia, Dept Psychiat & Neurogenet, Hollywood Private Hosp, Nedlands, WA 6009, Australia
[3] CHU Vaudois, Univ Inst Pathol, Div Neuropathol, CH-1011 Lausanne, Switzerland
[4] CHU Vaudois, Dept Neurol, CH-1011 Lausanne, Switzerland
[5] Psychiat & Psychogeriatry Nant, CH-1804 Corsier Sur Vevey, Switzerland
[6] New York State Inst Basic Res Dev Disabil, Dept Immunol, Staten Isl, NY 10314 USA
[7] Univ Melbourne, Alfred Hosp, NHMRC Dementia Brain Bank, Melbourne, Vic 3010, Australia
[8] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[9] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[10] Univ Sydney, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia
[11] Concord Repatriat Gen Hosp, Concord, NSW 2139, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
early-onset familial Alzheimer's disease; presenilin-1; mutation; tetraspasticity; pyramidal signs; motor dysfunction; primary motor cortex;
D O I
10.1016/S0197-4580(02)00192-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Mutations in the gene encoding presenilin 1 (PS-1) account for 50% of early-onset familial Alzheimer's disease (EOFAD) cases. In this study, we identified two missense mutations in the coding sequence of the presenilin (PS-1) gene in two EOFAD pedigrees. AD was confirmed in one pedigree by autopsy. Mutation analysis of PCR products amplified from genomic DNA templates showed two novel PS-1 mutations resulting in Gln222His and Tyr256Ser. The two novel mutations are located within predicted transmembrane domains five (TM-5) and six (TM-6), respectively, and are associated with very early ages of onset. The Tyr256Ser is associated with one of the youngest age of AD onset, 25 years, which is consistent with a drastic change in function of the altered PS-1 protein. A morphometric analysis of the cortical degenerative changes of the Tyr256Ser case, showed severe involvement of the primary motor cortex, which correlated well with the pyramidal changes, including tetraspasticity. Immunoblot analysis showed the Tyr256Ser case had the greatest expression of Abeta(1-40) and Abeta(1-42), which was confirmed by ELISA, compared to other PS-1 mutant FAD cases and age-matched controls and, thus, contributes to the severity of the disease pathology. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 34 条
[1]   Consensus recommendations for the postmortem diagnosis of Alzheimer's disease [J].
Ball, M ;
Braak, H ;
Coleman, P ;
Dickson, D ;
Duyckaerts, C ;
Gambetti, P ;
Hansen, L ;
Hyman, B ;
Jellinger, K ;
Markesbery, W ;
Perl, D ;
Powers, J ;
Price, J ;
Trojanowski, JQ ;
Wisniewski, H ;
Phelps, C ;
Khachaturian, Z .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S1-S2
[2]   STAGING OF ALZHEIMER-RELATED CORTICAL DESTRUCTION [J].
BRAAK, H ;
BRAAK, E ;
BOHL, J .
EUROPEAN NEUROLOGY, 1993, 33 (06) :403-408
[3]   A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years [J].
Campion, D ;
Brice, A ;
Dumanchin, C ;
Puel, M ;
Baulac, M ;
delaSayette, V ;
Hannequin, D ;
Duyckaerts, C ;
Michon, A ;
Martin, C ;
Moreau, V ;
Penet, C ;
Martinez, M ;
ClergetDarpoux, F ;
Agid, Y ;
Frebourg, T .
NEUROREPORT, 1996, 7 (10) :1582-1584
[4]   Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice [J].
Citron, M ;
Westaway, D ;
Xia, WM ;
Carlson, G ;
Diehl, T ;
Levesque, G ;
JohnsonWood, K ;
Lee, M ;
Seubert, P ;
Davis, A ;
Kholodenko, D ;
Motter, R ;
Sherrington, R ;
Perry, B ;
Yao, H ;
Strome, R ;
Lieberburg, I ;
Rommens, J ;
Kim, S ;
Schenk, D ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ .
NATURE MEDICINE, 1997, 3 (01) :67-72
[5]   THE STRUCTURE OF THE PRESENILIN-1 (S182) GENE AND IDENTIFICATION OF 6 NOVEL MUTATIONS IN EARLY-ONSET AD FAMILIES [J].
CLARK, RF ;
HUTTON, M ;
FULDNER, RA ;
FROELICH, S ;
KARRAN, E ;
TALBOT, C ;
CROOK, R ;
LENDON, C ;
PRIHAR, G ;
HE, C ;
KORENBLAT, K ;
MARTINEZ, A ;
WRAGG, M ;
BUSFIELD, F ;
BEHRENS, MI ;
MYERS, A ;
NORTON, J ;
MORRIS, J ;
MEHTA, N ;
PEARSON, C ;
LINCOLN, S ;
BAKER, M ;
DUFF, K ;
ZEHR, C ;
PEREZTUR, J ;
HOULDEN, H ;
RUIZ, A ;
OSSA, J ;
LOPERA, F ;
ARCOS, M ;
MADRIGAL, L ;
COLLINGE, J ;
HUMPHREYS, C ;
ASHWORTH, A ;
SARNER, S ;
FOX, N ;
HARVEY, R ;
KENNEDY, A ;
ROQUES, P ;
CLINE, RT ;
PHILLIPS, CA ;
VENTER, JC ;
FORSELL, L ;
AXELMAN, K ;
LILIUS, L ;
JOHNSTON, J ;
COWBURN, R ;
VIITANEN, M ;
WINBLAD, B ;
KOSIK, K .
NATURE GENETICS, 1995, 11 (02) :219-222
[6]   A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 [J].
Crook, R ;
Verkkoniemi, A ;
Perez-Tur, J ;
Mehta, N ;
Baker, M ;
Houlden, H ;
Farrer, M ;
Hutton, M ;
Lincoln, S ;
Hardy, J ;
Gwinn, K ;
Somer, M ;
Paetau, A ;
Kalimo, H ;
Ylikoski, R ;
Pöyhönen, M ;
Kucera, S ;
Haltia, M .
NATURE MEDICINE, 1998, 4 (04) :452-455
[7]   MOLECULAR-GENETIC ANALYSIS OF FAMILIAL EARLY-ONSET ALZHEIMERS-DISEASE LINKED TO CHROMOSOME 14Q24.3 [J].
CRUTS, M ;
BACKHOVENS, H ;
WANG, SY ;
VANGASSEN, G ;
THEUNS, J ;
DEJONGHE, C ;
WEHNERT, A ;
DEVOECHT, J ;
DEWINTER, G ;
CRAS, P ;
BRUYLAND, M ;
DATSON, N ;
WEISSENBACH, J ;
DENDUNNEN, JT ;
MARTIN, JJ ;
HENDRIKS, L ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2363-2371
[8]   Protein topology of presenilin 1 [J].
Doan, A ;
Thinakaran, G ;
Borchelt, DR ;
Slunt, HH ;
Ratovitsky, T ;
Podlisny, M ;
Selkoe, DJ ;
Seeger, M ;
Gandy, SE ;
Price, DL ;
Sisodia, SS .
NEURON, 1996, 17 (05) :1023-1030
[9]   EARLY-ONSET ALZHEIMERS-DISEASE - CLINICAL PREDICTORS OF INSTITUTIONALIZATION AND DEATH [J].
HEYMAN, A ;
WILKINSON, WE ;
HURWITZ, BJ ;
HELMS, MJ ;
HAYNES, CS ;
UTLEY, CM ;
GWYTHER, LP .
NEUROLOGY, 1987, 37 (06) :980-984
[10]   Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease [J].
Hutton, M ;
Busfield, F ;
Wragg, M ;
Crook, R ;
PerezTur, J ;
Clark, RF ;
Prihar, G ;
Talbot, C ;
Phillips, H ;
Wright, K ;
Baker, M ;
Lendon, C ;
Duff, K ;
Martinez, A ;
Houlden, H ;
Nichols, A ;
Karran, E ;
Roberts, G ;
Roques, P ;
Rossor, M ;
Venter, JC ;
Adams, MD ;
Cline, RT ;
Phillips, CA ;
Fuldner, RA ;
Hardy, J ;
Goate, A .
NEUROREPORT, 1996, 7 (03) :801-805